GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newbury Pharmaceuticals AB (OSTO:NEWBRY) » Definitions » Research & Development

Newbury Pharmaceuticals AB (OSTO:NEWBRY) Research & Development : kr0.00 Mil (TTM As of Aug. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Newbury Pharmaceuticals AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Newbury Pharmaceuticals AB's Research & Development for the three months ended in Aug. 2024 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Aug. 2024 was kr0.00 Mil.

Newbury Pharmaceuticals AB Research & Development Historical Data

The historical data trend for Newbury Pharmaceuticals AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newbury Pharmaceuticals AB Research & Development Chart

Newbury Pharmaceuticals AB Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Research & Development
- - - -

Newbury Pharmaceuticals AB Quarterly Data
Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Newbury Pharmaceuticals AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Newbury Pharmaceuticals AB  (OSTO:NEWBRY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Newbury Pharmaceuticals AB Research & Development Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Newbury Pharmaceuticals AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newbury Pharmaceuticals AB (OSTO:NEWBRY) » Definitions » Research & Development
Comparable Companies
XSAT:ACUC OSTO:KLAR XSAT:ODI XSAT:PMED OSTO:VIVE XSAT:DANCAN OSTO:TOL OSTO:GABA OSTO:ERMA OSTO:NANEXA ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
N/A
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Website
https://www.newburypharma.com
Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.

Newbury Pharmaceuticals AB Headlines

No Headlines